KAI 9803: Clinical Trials

1 trial of KAI 9803, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow KAI 9803: new trials by email Literature Review of KAI 9803 trials Research Report on KAI 9803

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack
KAI-9803 for Injection, Placebo - Myocardial Infarction
Phase 1 / Phase 2CompletedKAI Pharmaceuticals1542004-09-012011-09-02

Conditions studied

Myocardial Infarction (1)

Sponsors

KAI Pharmaceuticals (1)

Countries

United States (1)